Announcements

Group 1 Automotive, Inc. filed a Form 8-K with the SEC on September 8, 2026, announcing its intention to offer $1.25 billion in aggregate principal amount of senior unsecured notes in a private offering.

Strive, Inc. filed a Form 8-K on September 8, 2026, disclosing a bitcoin purchase of 1,375 bitcoin between August 31 and September 4, 2026, and providing updated holdings and share count data as of September 4, 2026.

General Electric Company, operating as GE Aerospace, filed a Form 8-K with the SEC on September 8, 2026, disclosing an agreement to acquire Consolidated Precision Products for a cash purchase price of $11.75 billion, subject to closing adjustments.

Definium Therapeutics, Inc. filed a current report on Form 8-K on September 8, 2026, disclosing that the U.S. Food and Drug Administration granted breakthrough designation to its DT120 ODT program for the treatment of major depressive disorder.

Spyre Therapeutics, Inc. filed a Form 8-K on September 8, 2026, disclosing 12-week induction topline data from Part A of its Phase 2 SKYLINE trial evaluating SPY003 in moderately-to-severely active ulcerative colitis.

Relmada Therapeutics, Inc. filed a Form 8-K on September 8, 2026, disclosing that Dr. Raj S. Pruthi's employment as Chief Medical Officer - Urology ended on September 3, 2026.

DPC Holdings PLC filed a Form 8-K with the SEC on September 8, 2026, disclosing that on September 3, 2026, the company and certain subsidiaries entered into a new $325 million senior unsecured revolving credit facility with Barclays Bank PLC as administrative agent, while …